Traws Pharma (TRAW) Change in Cash (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Change in Cash of -$687000.0 for Q1 2026, up 87.28% year-over-year from -$366830.2 in Q1 2025, and up 73.58% quarter-over-quarter from -$2.6 million in Q4 2025.
Traws Pharma (TRAW) Change in Cash (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Change in Cash for 15 consecutive years, with -$687000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 87.28% year-over-year to -$687000.0; the TTM figure through Mar 2026 stood at -$12.8 million (down 2726.49% YoY), while the FY2025 annual figure was -$17.5 million, down 3488.39% from the prior year.
- Change in Cash climbed to -$687000.0 in Q1 2026 per TRAW's latest filing, from -$2.6 million in the prior quarter.
- Across five years, Change in Cash topped out at $15.9 million in Q4 2024 and bottomed at -$11.5 million in Q3 2024.
- Historically, Change in Cash has averaged -$3.1 million across 5 years, with a median of -$4.3 million in 2022.
- Annual changes were most pronounced in 2024 — Change in Cash surged 460.12% — and 2025, when it sank 675.81%.
- Traws Pharma's Change in Cash stood at -$3.9 million in 2022, then slipped by 14.7% to -$4.4 million in 2023, then soared by 460.12% to $15.9 million in 2024, then sank by 116.32% to -$2.6 million in 2025, then soared by 73.58% to -$687000.0 in 2026.
- Business Quant data shows TRAW's Change in Cash at -$687000.0 in Q1 2026, -$2.6 million in Q4 2025, and -$6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - | 1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -687,000.00 |
| Dec 31, 2025 | -2.60 Mn |
| Sep 30, 2025 | -6.66 Mn |
| Jun 30, 2025 | -2.86 Mn |
| Mar 31, 2025 | -5.40 Mn |
| Dec 31, 2024 | 15.93 Mn |
| Sep 30, 2024 | -11.48 Mn |
| Jun 30, 2024 | 496,000.00 |
| Mar 31, 2024 | -4.43 Mn |
| Dec 31, 2023 | -4.42 Mn |
| Sep 30, 2023 | -4.49 Mn |
| Jun 30, 2023 | -4.49 Mn |
| Mar 31, 2023 | -4.54 Mn |
| Dec 31, 2022 | -3.86 Mn |
| Sep 30, 2022 | -3.92 Mn |
| Jun 30, 2022 | -4.23 Mn |
| Mar 31, 2022 | -4.30 Mn |
| Dec 31, 2021 | -4.31 Mn |
| Sep 30, 2021 | 15.67 Mn |
| Jun 30, 2021 | -4.30 Mn |